Prostate-specific antigen response rate of sequential chemotherapy in castration-resistant prostate cancer: the results of real life practice

PURPOSE: Prostate-specific antigen (PSA) response rate (>50% PSA decline in pretreatment PSA following chemotherapy) carries a significant survival advantage in castration-resistant prostate cancer (CRPC). We compared PSA response rates in first-, second- and third-line chemotherapy after failure...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Song, Geehyun, Lee, Chunwoo, You, Dalsan, Jeong, In Gab, Hong, Jun Hyuk, Ahn, Hanjong, Kim, Choung-Soo
Formato: Artigo
Idioma:Inglês
Publicado em: Asian Pacific Prostate Society (APPS) 2013
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3814118/
https://ncbi.nlm.nih.gov/pubmed/24223414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12954/PI.13024
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados